Jochen Zimmer, PhD, professor of molecular physiology and biomedical physics, is one of 33 scientists from across the country selected out of more than 800 applicants.
COVID-19 Updates: Get the latest information on appointment scheduling and safety measures.
Category: News Briefs
The goal of this annual symposium is to bring together internationally renowned cancer researchers and clinicians to present their findings on a timely area of cancer research.
UVA Health is offering monoclonal antibody drugs for appropriate patients with COVID-19 who are at highest risk for developing severe symptoms and requiring hospitalization.
Find out how you can get involved in shaping the strategic vision for the future of UVA Health.
One of just 52 nationally, UVA Cancer Center is the only Comprehensive Cancer Center in Virginia.
With the continued evolution of the COVID-19 virus comes new information on testing, vaccination and treatment. UVA infectious disease specialists Patrick Jackson, MD, and Debbie-Ann Shirley, MD, provide helpful updates on these important topics and more.
New research from UVA Cancer Center's Rajesh Balkrishnan, PhD, suggests that common blood pressure drugs may improve survival for patients with colorectal cancer.
See the latest news updates to learn how UVA Health is making an impact in the midst of this global health crisis and responding to the latest surge in cases of the delta variant.
These cellular sensors detect subtle changes in blood pressure and adjust hormone levels to keep it in check.
Through this new affiliation, the two independent health systems will further their collaboration in new areas, including malignant hematology, kidney transplant and physician recruitment.